| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-09 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-09 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-09 |